What steps should be taken to manage a patient on polypharmacy (multiple medications) for non-communicable diseases (NCDs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Systematic Approach to Managing Polypharmacy in NCD Patients

A comprehensive medication review should be performed at least annually for all patients on multiple medications for non-communicable diseases to optimize therapy, reduce adverse events, and improve outcomes. 1

Step 1: Medication Reconciliation and Assessment

  • Create an accurate medication list including all prescriptions, over-the-counter medications, supplements, and herbal remedies to identify discontinued, missing, or incorrectly taken medications 2, 1
  • Document all known diagnoses, conditions, existing laboratory results, and medication-related problems in the electronic medical record 2
  • Use validated tools like the Morisky Medication Adherence Scale to identify adherence barriers and review pill boxes, medication bottles, and fill dates 2, 1
  • Assess medication administration difficulties, treatment burden, and patient's ability to manage their regimen 2

Step 2: Interaction Assessment

  • Evaluate potential drug-drug interactions using interaction databases, paying particular attention to QT prolongation risks, anticoagulant interactions, and serotonin syndrome potential 2, 1
  • Identify medications that may worsen existing conditions (drug-disease interactions), such as NSAIDs in heart failure, chronic kidney disease, or hypertension 2
  • Look for duplicate therapies or medications with additive side effects that could result in toxicity 2, 1
  • Assess for prescribing cascades where medications are added to treat side effects of other medications 2

Step 3: High-Risk Medication Identification

  • Use validated tools like Beers Criteria or STOPP/START to identify potentially inappropriate medications in older adults 2, 1
  • Pay special attention to high-risk drug classes including sedatives/hypnotics, opioids, anticholinergics, benzodiazepines, anxiolytics, and hypoglycemics 2
  • Evaluate the risk-benefit ratio of each medication, considering the patient's age, renal function, and other comorbidities 2
  • Adjust doses based on declining kidney function using laboratory-reported clearance estimates 1

Step 4: Patient Preferences and Goal Setting

  • Discuss with the patient the purpose of medication optimization to improve quality of life and function 2
  • Encourage patients to express their personal values, aims, and priorities regarding treatment 2
  • Establish disease and treatment burden, including effects on daily life, mental health, general wellbeing, and quality of life 2
  • Involve family members or caregivers in the assessment process when appropriate 2

Step 5: Deprescribing When Appropriate

  • Target medications from which patients no longer derive reasonable benefit 2
  • Consider deprescribing when potential harm outweighs benefit, including education about risks for patients and families 1
  • Implement gradual tapering of high-risk medications rather than abrupt discontinuation 1
  • Monitor for withdrawal symptoms or disease recurrence after medication discontinuation 2, 3

Step 6: Monitoring and Follow-Up

  • Schedule regular follow-up appointments to assess medication effectiveness and adverse effects 2
  • Increase monitoring frequency during care transitions (hospital admission, transfers between wards, discharge) 2
  • Coordinate care among multiple prescribers to prevent duplication and ensure medication appropriateness 1
  • Document changes to the medication regimen and communicate these to all healthcare providers involved in the patient's care 2

Common Pitfalls to Avoid

  • Focusing only on the number of medications rather than their appropriateness 1
  • Overlooking non-prescription medications and supplements in the assessment 1, 4
  • Failing to consider patient preferences and treatment goals when optimizing medications 1
  • Neglecting to monitor for adverse effects or disease recurrence after medication changes 3
  • Inadequate communication between multiple healthcare providers leading to uncoordinated care 2

Special Considerations for NCD Management

  • Assess the management of chronic pain, depression, anxiety, and other common comorbidities 2
  • Evaluate physiological and functional status, nutritional and hydration requirements 2
  • Consider using a multidisciplinary team approach, especially involving clinical pharmacists when available 1
  • Utilize computerized alerts and decision support tools when possible to improve medication management 1, 5

References

Guideline

Systematic Approach to Managing Polypharmacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Polypharmacy: the challenge for nurses.

Nursing standard (Royal College of Nursing (Great Britain) : 1987), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.